Christophe Schmitt
10PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 04, 2026
Novel selective morpholine trace amine-associated receptor 1 partial agonists show promising preclinical effects for neuropsychiatric disorders and are well tolerated in healthy volunteers.Céline Fournier, Danièle Buchy, Susanne Mohr
|Aug 02, 2023
Clinical pharmacology of emicizumab for the treatment of hemophilia A.Koichiro Yoneyama, Christophe Schmitt, Agnès Portron
|Jun 06, 2022
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study.Christophe Schmitt, Laura Brockwell, Mylène Giraudon
|Mar 14, 2022
Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5).Renchi Yang, Shujie Wang, Xuefeng Wang
|Sep 21, 2021
A Model-Based Framework to Inform the Dose Selection and Study Design of Emicizumab for Pediatric Patients With Hemophilia A.Koichiro Yoneyama, Christophe Schmitt, Tiffany Chang
|Sep 04, 2021
Low immunogenicity of emicizumab in persons with haemophilia A.Christophe Schmitt, Thomas Emrich, Sammy Chebon
Pageof 2
Frequent Collaborators
3 joint publications
Koichiro Yoneyama
2 joint publications
Sylvie Retout
1 joint publications
Ryu Kasai
1 joint publications
Fredrik Jonsson
1 joint publications
Francois Mercier
1 joint publications
Renchi Yang
1 joint publications
Ampaiwan Chuansumrit
1 joint publications
Anna Kiialainen
1 joint publications
Naoki Kotani
1 joint publications
Joanne I Adamkewicz
